Global, regional, and national burden of HIV among children aged 0-14 years: Estimates and socioeconomic inequalities, 1990-2021 [0.03%]
1990至2021年全球、区域和国家儿童青少年HIV疾病负担及社会经济不平等估算（0～14岁）
Xinxin Zhang,Chen Li,Yue Zhang et al.
Xinxin Zhang et al.
Introduction: Children are a priority group for HIV prevention and control. However, limited data exist regarding disease burden and temporal trends among this population. This study aimed to evaluate the burden of HIV, a...
Effects of transition from paediatric to adult HIV care on virological outcomes in sub-Saharan Africa: A systematic review and meta-analysis [0.03%]
东非国家艾滋病患儿过渡到成人护理后病毒学结果系统评价和meta分析
Petra E Joseph,Annabel M Itaeli,Maryam Amour et al.
Petra E Joseph et al.
Background: HIV remains a major global burden, with 2.4 million children and adolescents affected, 84% living in sub-Saharan Africa. As adolescents age, transitioning from paediatric to adult HIV care represents a critica...
Review
HIV medicine. 2026 Mar 13. DOI:10.1111/hiv.70221 2026
Late diagnosis of HIV persists in Sweden: Differing social determinants among migrant and non-migrant people with HIV [0.03%]
瑞典艾滋病晚期诊断依然存在：艾滋病患者中移民和非移民人群社会决定因素差异
Sara Falk,Josefin Nilsson,Isabela Killander Möller et al.
Sara Falk et al.
Objective: To examine temporal changes in late diagnosis of HIV (LD) among migrant and non-migrant people with HIV in Sweden 2003-2023 and to assess demographic and socioeconomic risk factors for LD in these two populatio...
The impact of accumulating immune adaptation in circulating strains of HIV-1 [0.03%]
HIV-1循环菌株累积免疫适应的影响
Marwah Al-Kaabi,Alison Castley,Pooja Deshpande et al.
Marwah Al-Kaabi et al.
Background: Mutations in human immunodeficiency virus type 1 (HIV-1) enable the virus to evade recognition and killing by human leucocyte antigen (HLA)-restricted T cells. These viral adaptations are specific to the HLA t...
Real-world use of second-generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS-CO3-AquiVIH-NA cohort [0.03%]
法国ANRS-CO3-AquiVIH-NA队列中二代整合酶链转移抑制剂（INSTIs）作为换药治疗的现实世界使用情况
O Leleux,A Peyrouny-Mazeau,A Perrier et al.
O Leleux et al.
Objectives: To characterize real-world treatment switching in France to bictegravir (BIC or B) or dolutegravir (DTG)-based regimens with a focus on treatment persistence, effectiveness (HIV-1 RNA ≤50 copies/ml) and parti...
Clinical management of detectable viraemia during CAB/RPV long-acting therapy: Are really PIs the only exit strategies? [0.03%]
CAB/RPV长效治疗期间可检测到病毒血症的临床处理：PIs真的是唯一可行的方法吗？
P F Salvo,F Lombardi,C Torti et al.
P F Salvo et al.
Perianal lesions in men who have sex with men living with HIV: Risk of precancer and cancer [0.03%]
HIV阳性男性同性性行为者肛周病变与癌变和癌前病变风险的关系研究
Shima Rastegar,Michael M Gaisa,Xinyang Xu et al.
Shima Rastegar et al.
Objectives: Men who have sex with men living with HIV (MSMLWH) are at highest risk for human papillomavirus (HPV)-associated anal cancer, which may originate from the anal canal, verge or perianal skin. Perianal lesions a...
Disability and frailty in people living with Human Immunodeficiency Virus in regional Australia: A cross-sectional study with a measurement property assessment of the HIV Disability Questionnaire [0.03%]
澳大利亚地区人类免疫缺陷病毒携带者的残疾和虚弱状况：HIV残疾问卷测量属性评估的横断面研究
Carol Ann Flavell,Michael Crowe,Penny Kenchington et al.
Carol Ann Flavell et al.
Objectives: To measure disability and frailty and assess measurement properties of the HIV Disability Questionnaire (HDQ) in outer regional Australian people living with human immunodeficiency virus (HIV). ...
Nina Weis,Mimie Chirwa,Caroline A Sabin;EACS‐WAVE and BHIVA Women&#x;s Special Interest Group
Nina Weis
Editorial
HIV medicine. 2026 Mar 3. DOI:10.1111/hiv.70213 2026
Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system [0.03%]
基于美国食品药品监督管理部门不良事件监测系统的整合酶抑制剂相关体重增加及糖脂代谢异常不良反应的信号检测研究
Leidan Zhang,Ling Chen,Jia Tang et al.
Leidan Zhang et al.
Objective: Integrase strand transfer inhibitors (INSTIs) are widely used in antiretroviral therapy (ART) for people with HIV due to their efficacy and tolerability. However, concerns about weight gain and metabolic distur...